Trials / Completed
CompletedNCT01246336
Exploratory Study Using Nanotechnology to Detect Biomarkers of Parkinson's Disease From Exhaled Breath
Exploratory Study to Detect Volatile Biomarkers of Idiopathic Parkinson's Disease and Parkinsonism From Exhaled Breath Using a Nanomedical Artificial Olfactory System.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 41 (actual)
- Sponsor
- Rambam Health Care Campus · Academic / Other
- Sex
- All
- Age
- 30 Years
- Healthy volunteers
- Accepted
Summary
Parkinson's disease is diagnosed clinically, because biomarkers that may help in diagnosis and differential diagnosis are not yet available. Exhaled breath testing may yield a "breath-print" that can be used to distinguish healthy and diseased states.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | collection of exhaled breath | no intervention |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2012-01-01
- Completion
- 2012-01-01
- First posted
- 2010-11-23
- Last updated
- 2017-10-31
Source: ClinicalTrials.gov record NCT01246336. Inclusion in this directory is not an endorsement.